Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Carl Heneghan and Dr Ben Goldacre in the top 100 clinical leaders.

Pictured left to right: Professor Carl Heneghan and Dr Ben Goldacre
Pictured left to right: Professor Carl Heneghan and Dr Ben Goldacre

The Health Service Journal (HSJ) has announced this year’s Clinical Leaders list, which includes Professor Carl Heneghan and Dr Ben Goldacre from Oxford University’s Nuffield Department of Primary Care Health Sciences.

Now in its third year, the list highlights those clinicians influencing policy, innovation and service transformation.

100 individuals from across the spectrum of healthcare have made the list, with the top 20 Clinical Leaders ranked. The names were put forward by the HSJ’s readers and in-house team of experts for a panel of judges to consider. Around 80 healthcare leaders and guests attended a private reception in London on Monday 6 July to celebrate their success.

Carl Heneghan is Professor of Evidence Based Medicine, Director of the Centre for Evidence Based Medicine in Oxford, a General Practitioner and a Senior Tutor of Kellogg College. He is the director in programmes for Evidence-Based Health Care, in conjunction with the Department of Continuing Education.

As a clinical epidemiologist, his work focuses on improving the evidence-base to change practice and his research includes treatment of communicable disease in primary care with recent work investigating the effectiveness of the controversial drug Tamiflu. He currently chairs the WHO guidelines on self-care and cardiovascular disease risk and co-directs the WHO Collaborating Centre on Self-Care. Professor Heneghan also investigates the evidence base for publication bias and drug and device regulation, and advises governments on the regulatory and evidence requirements for devices and drugs. He is also a founder of AllTrials campaign. Carl Heneghan also appeared on the 2013 list.

Ben Goldacre, who joined the department in 2015, is a Senior Clinical Research Fellow working in the Centre for Evidence Based Medicine on quantitative research and policy analysis around publication bias, evidence-based policy, variation in prescribing and retracted papers. He is a best-selling author, broadcaster, campaigner and medical doctor, known for his books “Bad Science” and “Bad Pharma” and for co-founding the AllTrials campaign, which is now supported by over 50,000 individuals, 120 patient groups, GSK and all major academic and medical bodies in the UK. The campaign works towards a concrete fix for the ongoing problem of clinical trials results being withheld. He has given evidence to multiple parliamentary select committees including the Public Accounts Committee, Science and Technology, Health, and Culture Media & Sport.

Commenting on the list in a recent HSJ article, Dave West, HSJ Senior Bureau Chief, Commissioning and Performance wrote:

“These are people who tell the tale of where clinical leadership stands today in the health service.”

The top 5 clinical leaders named by HSJ are:

  1. Professor Sir Bruce Keogh, Medical Director of NHS England
  2. Professor Sir Mike Richards, Chief Inspector of Hospitals, Care Quality Commission
  3. Professor Dame Sally Davies, Chief Medical Officer for England, Department of Health
  4. Professor Steve Field, Chief Inspector of GPs, Care Quality Commission
  5. Dr  Sarah Wollaston, MP for Totnes and Chair of the House of Commons Health Select Committee.

Also named in the top 100 from the University of Oxford is Regius Chair of Medicine, Professor Sir John Bell.

 

Contact our communications team

Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.